Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05321134 · ClinicalTrials.gov registry record · NA
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
A NA study of Colo-rectal Cancer and Colorectal Disorders, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05321134 is a NA study of Colo-rectal Cancer and Colorectal Disorders that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 25 participants, below the 2,805-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05321134, a NA study of Colo-rectal Cancer and Colorectal Disorders, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently a multiport robotic surgery platform (Intuitive Xi) is widely available and used for colorectal surgery indications. A Single port platform (Intuitive SP) is FDA approved for Head and Neck and Urology but has not been widely used in colorectal surgery. This study seeks to evaluate the safe and effective use of the SP platform for colorectal surgery indications.
Conditions Studied
Interventions
- DEVICE Single port robotic colorectal surgical procedure
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05321134
The ClinicalTrials.gov registry entry for NCT05321134 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,805-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Colo-rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Single port robotic colorectal surgical procedure is the first listed.
NCT05321134 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05321134 about?
NCT05321134 is a clinical study titled "Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery". Currently a multiport robotic surgery platform (Intuitive Xi) is widely available and used for colorectal surgery indications. A Single port platform (Intuitive SP) is FDA approved for Head and Neck and Urology but has not been widely used in colorectal surgery. This study seeks to evaluate the safe...
What is the current status of trial NCT05321134?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-04-28. Estimated completion is 2028-04.
What conditions does trial NCT05321134 study?
This clinical trial studies the following conditions: Colo-rectal Cancer, Colorectal Disorders, Rectal Prolapse, Colostomy Stoma.
What interventions are being tested in trial NCT05321134?
The interventions under investigation include: Single port robotic colorectal surgical procedure (DEVICE).
Who is sponsoring clinical trial NCT05321134?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05321134 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colo-rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
RECRUITING · NA
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
RECRUITING · Phase 2
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RECRUITING · Phase 1
-
Shield Post-Approval Study Protocol
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.